A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
Risk factors associated with acute respiratory illnesses in athletes: a systematic review by a subgroup of the IOC consensus on 'acute respiratory illness in the athlete'
Tekijät: Derman Wayne, Badenhorst Marelise, Eken Maaike, Gomez-Ezeiza Josu, Fitzpatrick Jane, Gleeson Maree, Kunorozva Lovemore, Mjösund Katja, Mountjoy Margo, Sewry Nicola, Schwellnus Martin
Kustantaja: BMJ PUBLISHING GROUP
Julkaisuvuosi: 2022
Journal: British Journal of Sports Medicine
Tietokannassa oleva lehden nimi: BRITISH JOURNAL OF SPORTS MEDICINE
Lehden akronyymi: BRIT J SPORT MED
Sivujen määrä: 13
ISSN: 0306-3674
eISSN: 1473-0480
DOI: https://doi.org/10.1136/bjsports-2021-104795
Verkko-osoite: https://bjsm.bmj.com/content/early/2022/03/10/bjsports-2021-104795
Objective To review risk factors associated with acute respiratory illness (ARill) in athletes, including non-infectious ARill and suspected or confirmed acute respiratory infections (ARinf).
Design Systematic review.
Data sources Electronic databases: PubMed-Medline, EbscoHost and Web of Science.
Eligibility criteria Original research articles published between January 1990 and July 2020 in English were searched for prospective and retrospective full text studies that reported quantitative data on risk factors associated with ARill/ARinf in athletes, at any level of performance (elite/non-elite), aged 15-65 years.
Results 48 studies (n=19 390 athletes) were included in the study. Risk factors associated with ARill/ARinf were: increased training monotony, endurance training programmes, lack of tapering, training during winter or at altitude, international travel and vitamin D deficits. Low tear-(SIgA) and salivary-(IgA) were immune biomarkers associated with ARill/ARinf.
Conclusions Modifiable training and environmental risk factors could be considered by sports coaches and athletes to reduce the risk of ARill/ARinf. Clinicians working with athletes can consider assessing and treating specific nutritional deficiencies such as vitamin D. More research regarding the role and clinical application of measuring immune biomarkers in athletes at high risk of ARill/ARinf is warranted.
PROSPERO registration number CRD42020160928.
